Banco Santander Brasil SA (BSBR)
Buenos Aires Exchange · Argentina · prices in ARS · close of 22 Oct 2026
Key indicators
| Last close | ARS 9,015.00 |
|---|---|
| 52-week range | 7,460.00 – 11,060.00 |
| Return, 1 month / 3 months | −3.9% / +5.3% |
| Return, 1 year / 3 years | +3.7% / +76.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 46 |
| Volatility (1 year) | 37.6% |
| Worst drawdown (1 year) | -26.8% |
| Average daily value traded | 18.54M ARS |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Banco Santander Brasil is a bank that serves individuals and companies in Brazil. It offers everyday banking such as current accounts, savings, personal loans, credit cards and mortgages, along with investment and insurance products. For businesses it provides lending, cash management and trade finance. The bank is based in São Paulo and operates through a branch network across the country, serving retail customers, small and medium-sized enterprises and larger corporate clients.
Banco Santander Brasil SA trades under the code BSBR on the Buenos Aires Exchange in Argentina, with its price quoted in Argentine pesos (ARS). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Banco Santander Brasil SA (BSBR) trades on the Buenos Aires Exchange in Argentina. It last closed at ARS 9,015.00 on 22 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 91 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 3.7% and over the last three months it rose 5.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Buenos Aires Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 52 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.8% | ||
| From 52-week high | -15.9% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 5.3% | ||
| 6-month return | -0.7% | ||
| 12-month return, skipping the last month | 8.0% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 37.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.8% | ||
| Liquidity | 27 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 18.54M ARS | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.3% |
|---|---|
| 1 month | −3.9% |
| 3 months | +5.3% |
| 6 months | −0.7% |
| 1 year | +3.7% |
| 3 years | +76.8% |
| 5 years | +656.3% |
Signals
| 50-day / 200-day average | 9,231.90 / 8,942.77 |
|---|---|
| Golden / death cross (60 days) | Golden, 24 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 231.36 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Jul 2023 | BRL 16.9407 |
| 25 Apr 2023 | BRL 12.1062 |
| 27 Jan 2023 | BRL 12.2018 |
| 24 Oct 2022 | BRL 5.0723 |
| 12 Aug 2022 | BRL 7.7832 |
| 22 Apr 2022 | BRL 3.9200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Buenos Aires Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.